BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: O'Reilly VP, Wong L, Kennedy C, Elliot LA, O'Meachair S, Coughlan AM, O'Brien EC, Ryan MM, Sandoval D, Connolly E, Dekkema GJ, Lau J, Abdulahad WH, Sanders JS, Heeringa P, Buckley C, O'Brien C, Finn S, Cohen CD, Lindemeyer MT, Hickey FB, O'Hara PV, Feighery C, Moran SM, Mellotte G, Clarkson MR, Dorman AJ, Murray PT, Little MA. Urinary Soluble CD163 in Active Renal Vasculitis. J Am Soc Nephrol 2016;27:2906-16. [PMID: 26940094 DOI: 10.1681/ASN.2015050511] [Cited by in Crossref: 54] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Matsumoto K, Suzuki K, Yoshimoto K, Seki N, Tsujimoto H, Chiba K, Takeuchi T. Longitudinal immune cell monitoring identified CD14++ CD16+ intermediate monocyte as a marker of relapse in patients with ANCA-associated vasculitis. Arthritis Res Ther 2020;22:145. [PMID: 32546274 DOI: 10.1186/s13075-020-02234-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Gabilan C, Pfirmann P, Ribes D, Rigothier C, Chauveau D, Casemayou A, Huart A, Schanstra J, Colombat M, Faguer S, Belliere J. Avacopan as first-line treatment in ANCA-associated vasculitis: a steroid-sparing option. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.01.1065] [Reference Citation Analysis]
3 Cantero-Navarro E, Rayego-Mateos S, Orejudo M, Tejedor-Santamaria L, Tejera-Muñoz A, Sanz AB, Marquez-Exposito L, Marchant V, Santos-Sanchez L, Egido J, Ortiz A, Bellon T, Rodrigues-Diez RR, Ruiz-Ortega M. Role of Macrophages and Related Cytokines in Kidney Disease. Front Med (Lausanne) 2021;8:688060. [PMID: 34307414 DOI: 10.3389/fmed.2021.688060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Free ME, Falk RJ. The Search for a Biomarker of Relapse in ANCA-Associated Vasculitis. J Am Soc Nephrol 2016;27:2551-3. [PMID: 27160405 DOI: 10.1681/ASN.2016030347] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Rovin BH, Caster DJ, Cattran DC, Gibson KL, Hogan JJ, Moeller MJ, Roccatello D, Cheung M, Wheeler DC, Winkelmayer WC, Floege J. Management and treatment of glomerular diseases (part 2): Conclusions From A Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference. Nefrologiâ (St -Peterbg ) 2021;25:96-119. [DOI: 10.36485/1561-6274-2021-25-1-96-119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Morris AD, Morais CLM, Lima KMG, Freitas DLD, Brady ME, Dhaygude AP, Rowbottom AW, Martin FL. Distinguishing active from quiescent disease in ANCA-associated vasculitis using attenuated total reflection Fourier-transform infrared spectroscopy. Sci Rep 2021;11:9981. [PMID: 33976282 DOI: 10.1038/s41598-021-89344-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mejia-Vilet JM, Zhang XL, Cruz C, Cano-Verduzco ML, Shapiro JP, Nagaraja HN, Morales-Buenrostro LE, Rovin BH. Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis. J Am Soc Nephrol 2020;31:1335-47. [PMID: 32300067 DOI: 10.1681/ASN.2019121285] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
8 Fagni F, Bello F, Emmi G. Eosinophilic Granulomatosis With Polyangiitis: Dissecting the Pathophysiology. Front Med (Lausanne) 2021;8:627776. [PMID: 33718405 DOI: 10.3389/fmed.2021.627776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Dagostin MA, Nunes SLO, Shinjo SK, Pereira RMR. Mortality predictors in ANCA-associated vasculitis: Experience of a Brazilian monocentric cohort of a rheumatology center. Medicine (Baltimore) 2021;100:e28305. [PMID: 34941119 DOI: 10.1097/MD.0000000000028305] [Reference Citation Analysis]
10 Gong S, Jin S, Li Y, Jiang W, Zhang Z, Shen Z, Wang J, Zhou H, Liu X, Xu X, Ding X, Shi Y, Liu H. Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status. Front Immunol 2021;12:769802. [PMID: 35003086 DOI: 10.3389/fimmu.2021.769802] [Reference Citation Analysis]
11 Takei Y, Takahashi S, Nakasatomi M, Sakairi T, Ikeuchi H, Kaneko Y, Hiromura K, Nojima Y, Maeshima A. Urinary Activin A is a novel biomarker reflecting renal inflammation and tubular damage in ANCA-associated vasculitis. PLoS One 2019;14:e0223703. [PMID: 31613925 DOI: 10.1371/journal.pone.0223703] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
12 Siwan E, Twigg SM, Min D. Alterations of CD163 expression in the complications of diabetes: A systematic review. Journal of Diabetes and its Complications 2022. [DOI: 10.1016/j.jdiacomp.2022.108150] [Reference Citation Analysis]
13 Aierken X, Zhu Q, Wu T, Liu SS, Cao YY, Cai XT, Aihemaiti A, Bi Y, Yang S, Zhang W, Li N. Increased Urinary CD163 Levels in Systemic Vasculitis with Renal Involvement. Biomed Res Int 2021;2021:6637235. [PMID: 33997033 DOI: 10.1155/2021/6637235] [Reference Citation Analysis]
14 Rousselle A, Sonnemann J, Amann K, Mildner A, Lodka D, Kling L, Bieringer M, Schneider U, Leutz A, Enghard P, Kettritz R, Schreiber A. CSF2-dependent monocyte education in the pathogenesis of ANCA-induced glomerulonephritis. Ann Rheum Dis 2022:annrheumdis-2021-221984. [PMID: 35418479 DOI: 10.1136/annrheumdis-2021-221984] [Reference Citation Analysis]
15 Shochet L, Holdsworth S, Kitching AR. Animal Models of ANCA Associated Vasculitis. Front Immunol 2020;11:525. [PMID: 32373109 DOI: 10.3389/fimmu.2020.00525] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
16 Kronbichler A, Lee KH, Denicolò S, Choi D, Lee H, Ahn D, Kim KH, Lee JH, Kim H, Hwang M, Jung SW, Lee C, Lee H, Sung H, Lee D, Hwang J, Kim S, Hwang I, Kim DY, Kim HJ, Cho G, Cho Y, Kim D, Choi M, Park J, Park J, Tizaoui K, Li H, Smith L, Koyanagi A, Jacob L, Gauckler P, Shin JI. Immunopathogenesis of ANCA-Associated Vasculitis. Int J Mol Sci 2020;21:E7319. [PMID: 33023023 DOI: 10.3390/ijms21197319] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
17 Aendekerk JP, Timmermans SAMEG, Busch MH, Potjewijd J, Heeringa P, Damoiseaux JGMC, Reutelingsperger CP, van Paassen P; Limburg Renal Registry. Urinary Soluble CD163 and Disease Activity in Biopsy-Proven ANCA-Associated Glomerulonephritis. Clin J Am Soc Nephrol 2020;15:1740-8. [PMID: 33203735 DOI: 10.2215/CJN.07210520] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
18 Chen YX, Chen XN. Antineutrophil cytoplasmic antibodies-associated glomerulonephritis: From bench to bedside. Chronic Dis Transl Med 2018;4:187-91. [PMID: 30276365 DOI: 10.1016/j.cdtm.2018.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Dos Santos JP, Artigiani Neto R, Mangueira CLP, Filippi RZ, Gutierrez PS, Westra J, Brouwer E, de Souza AWS. Associations between clinical features and therapy with macrophage subpopulations and T cells in inflammatory lesions in the aorta from patients with Takayasu arteritis. Clin Exp Immunol 2020;202:384-93. [PMID: 32639582 DOI: 10.1111/cei.13489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Wu L, Wang G, Yang B, Liu X, Xie C, Feng X, Jin L, Zhou Z, Yang M, Zhou ZM, Su C, Li Y, Song Y, Cao W. Urinary Matrix Metalloproteinase 7 Activated by Oxidative Stress Predicts Kidney Prognosis in Myeloperoxidase-antineutrophil Cytoplasmic Antibody-associated Vasculitis. Antioxidants & Redox Signaling. [DOI: 10.1089/ars.2021.0188] [Reference Citation Analysis]
21 Moran SM, Monach PA, Zgaga L, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Pagnoux C, Seo P, Specks U, Sreih A, Wyse J, Ytterberg SR, Merkel PA, Little MA; Vasculitis Clinical Research Consortium. Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant 2020;35:283-91. [PMID: 30380100 DOI: 10.1093/ndt/gfy300] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
22 Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR, Kullman J, Lyons PA, Merkel PA, Savage COS, Specks U, Kain R. ANCA-associated vasculitis. Nat Rev Dis Primers 2020;6:71. [PMID: 32855422 DOI: 10.1038/s41572-020-0204-y] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 25.5] [Reference Citation Analysis]
23 Salama AD. Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)-Associated Vasculitis. Kidney Int Rep 2020;5:7-12. [PMID: 31922056 DOI: 10.1016/j.ekir.2019.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
24 Brogan P, Eleftheriou D. Vasculitis update: pathogenesis and biomarkers. Pediatr Nephrol 2018;33:187-98. [PMID: 28785984 DOI: 10.1007/s00467-017-3597-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
25 Sepe V, Libetta C, Gregorini M, Rampino T. The innate immune system in human kidney inflammaging. J Nephrol 2021. [PMID: 34826123 DOI: 10.1007/s40620-021-01153-4] [Reference Citation Analysis]
26 Cowhig C, Scott J, Dorman AM, Little MA, de Freitas DG. Acute renal allograft failure in a patient with vasculitis. Rheumatology (Oxford) 2021;60:iii43-6. [PMID: 34137875 DOI: 10.1093/rheumatology/keab045] [Reference Citation Analysis]
27 Draibe JB, Fulladosa X, Cruzado JM, Torras J, Salama AD. Current and novel biomarkers in anti-neutrophil cytoplasm-associated vasculitis. Clin Kidney J 2016;9:547-51. [PMID: 27478594 DOI: 10.1093/ckj/sfw056] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
28 Frantz C, Pezet S, Avouac J, Allanore Y. Soluble CD163 as a Potential Biomarker in Systemic Sclerosis. Dis Markers 2018;2018:8509583. [PMID: 29805720 DOI: 10.1155/2018/8509583] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
29 Cheung CK, McAdoo SP. Maintenance rituximab treatment for ANCA-associated vasculitis: to be continued? Rheumatology (Oxford) 2021;60:1010-2. [PMID: 33351955 DOI: 10.1093/rheumatology/keaa812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Cornec D, Kabat BF, Mills JR, Cheu M, Hummel AM, Schroeder DR, Cascino MD, Brunetta P, Murray DL, Snyder MR, Fervenza F, Hoffman GS, Kallenberg CGM, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, St Clair EW, Stone JH, Barnidge DR, Specks U. Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis. Rheumatology (Oxford) 2018;57:639-50. [PMID: 29340623 DOI: 10.1093/rheumatology/kex484] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
31 Villacorta J, Lucientes L, Goicoechea E, Acevedo M, Cavero T, Sanchez-Camara L, Díaz-Crespo F, Gimenez-Moyano S, García-Bermejo L, Fernandez-Juarez G. Urinary soluble CD163 as a biomarker of disease activity and relapse in antineutrophil cytoplasm antibody-associated glomerulonephritis. Clin Kidney J 2021;14:212-9. [PMID: 33564421 DOI: 10.1093/ckj/sfaa043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Fan X, Zhang X, Liu LC, Kim AY, Curley SP, Chen X, Dworkin LD, Cooper CJ, Gupta R. Interleukin-10 attenuates renal injury after myocardial infarction in diabetes. J Investig Med 2022:jim-2021-002008. [PMID: 35140126 DOI: 10.1136/jim-2021-002008] [Reference Citation Analysis]
33 Morris AD, Freitas DLD, Lima KMG, Floyd L, Brady ME, Dhaygude AP, Rowbottom AW, Martin FL. Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study. Molecules 2022;27:2312. [DOI: 10.3390/molecules27072312] [Reference Citation Analysis]
34 Droguett A, Valderrama G, Burgos ME, Carpio D, Saka C, Egido J, Ruiz-Ortega M, Mezzano S. Gremlin, A Potential Urinary Biomarker of Anca-Associated Crescentic Glomerulonephritis. Sci Rep 2019;9:6867. [PMID: 31053735 DOI: 10.1038/s41598-019-43358-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]